BioCentury
ARTICLE | Clinical News

Malaria vaccine: Phase I

December 16, 2002 8:00 AM UTC

RMF Dictagene SA, Lausanne, Switzerland Product: Malaria vaccine Business: Infectious diseases Therapeutic category: Immune stimulation Target: Plasmodium falciparum antigen Description: Synthetic pep...